2cureX AB (publ) announced the signature of an IndiTreat® distribution agreement for Romania with 2cureX AB (publ). 2cureX and Onco Systems have signed an agreement by which Onco Systems becomes the distributor of IndiTreat® products in Romania. Under the terms of the collaboration, Onco Systems will promote IndiTreat® to oncology professionals, sign supply agreements with hospitals and manage the sample logistics between the hospitals and the 2cureX labs in Copenhagen.

The standard treatments used in Romania for colorectal cancer patients are included in the current range of IndiTreat® tests (mCRC Start, mCRC Extend and mCRC Explore), so the guidance provided by IndiTreat® will be relevant for Romanian oncologists. The standard treatments used in Romania for colorectal cancer patients are included in the current range of IndiTreat® tests (mCRC Start, mCRC Extend and mCRC Explore) The agreement has been signed for an initial term of three years, with automatic renewal for successive terms. Other terms of the agreement have not been disclosed. Sales impact of this agreement is expected to show in 2023.